About the Company
Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially block tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients. Calithera is headquartered in South San Francisco, California.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CALA News
Calithera Biosciences Inc (CALA)
Calithera Biosciences, Inc. (NASDAQ:CALA) is a clinical-stage biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock ...
Calithera Biosciences Inc (CALA) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
MILLENNIUM PHARMACEUTICALS INC's Net Worth
MILLENNIUM PHARMACEUTICALS INC has an estimated net worth of $119 Million. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., Day One ...
CLRB Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug ...
Pacira BioSciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
TAKEDA PHARMACEUTICAL CO LTD's Net Worth
Who is TAKEDA PHARMACEUTICAL CO LTD? TAKEDA PHARMACEUTICAL CO LTD has an estimated net worth of $461 Million. This is based on reported shares across multiple companies, which include Calithera ...
Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
HRMY Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the ...
Aptose Biosciences Inc APTO
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Forte Biosciences Inc.
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic ...
Calithera Biosciences, Inc. (CALA)
May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the “Company”) announced that it intends to hold a special meeting of stockholders on or about June 29, 2023 (the “Special ...
Calithera Biosciences, Inc. (CALA)
May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the “Company”) announced that it intends to hold a special meeting of stockholders on or about June 29, 2023 (the “Special ...
Loading the latest forecasts...